Patent 9187741 was granted and assigned to Novozymes on November, 2015 by the United States Patent and Trademark Office.
The present invention relates to isolated polypeptides having endoglucanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.